Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
92,935,152
-
Total 13F shares
-
3,935,132
-
Share change
-
+376,493
-
Total reported value
-
$5,430,813
-
Price per share
-
$1.38
-
Number of holders
-
25
-
Value change
-
+$524,452
-
Number of buys
-
10
-
Number of sells
-
5
Institutional Holders of Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX) as of Q1 2024
As of 31 Mar 2024,
Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,935,132 shares.
The largest 10 holders included
Opaleye Management Inc., Ally Bridge Group (NY) LLC, VANGUARD GROUP INC, Affinity Asset Advisors, LLC, OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC), ADAR1 Capital Management, LLC, HighTower Advisors, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Mill Creek Capital Advisors, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
25
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.